Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Petco Health & Wellness Company's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Petco Health & Wellness Company's regulatory disclosures and financial reporting.
Petco Health & Wellness Company, Inc. Chief Human Resources Officer Holly May sold 250,000 shares of Class A common stock in open-market transactions. The sales occurred on July 7 and July 8, 2026 at a weighted average price of about $2.55 per share, executed across multiple trades within disclosed price ranges.
After these sales, she directly holds 1,527,867 shares of Class A common stock, which include 1,326,218 outstanding RSUs granted under the company’s 2021 Plan. Each RSU represents the right to receive one share of Class A common stock.
WOOF filed a Form 144 reporting a proposed sale of 200,000 Class A shares tied to restricted stock vesting on 04/15/2026. The filing also shows recent dispositions by Holly May of 100,000 Class A shares on 07/07/2026 for $255,242.38 and 150,000 Class A shares on 07/08/2026 for $381,831.29.
WOOF notice: proposed sales of Class A shares by affiliates are disclosed on a Form 144. The filing lists a recent sale of 100,000 Class A shares on 07/07/2026 for $255,242.38. It also records scheduled restricted stock vestings of 75,311 (04/15/2025), 40,689 (10/15/2025), 32,071 (03/04/2026) and 1,929 (04/15/2026) Class A shares. The filing shows shares outstanding were 247,774,472 as of 07/08/2026.
Murphy Glenn reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. director Glenn Murphy reported an equity award of Class A common stock. He received 60,662 restricted stock units (RSUs) at a price of $0.00 per share, granted under the Petco Health and Wellness Company, Inc. 2021 Equity Incentive Plan.
Each RSU represents one share of Class A common stock and will vest on the earlier of the company’s next annual shareholder meeting or June 30, 2027. Following this award, Murphy directly holds 1,060,662 Class A shares and has an additional 1,470,589 shares reported as indirectly owned through GSSB Corporation.
BRIGGS GARY S reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. director Gary S. Briggs received an equity award of 60,662 restricted stock units (RSUs) of Class A common stock as compensation. The grant was made at no cash cost to him and is issued under Petco’s 2021 Equity Incentive Plan.
Each RSU represents one share of Class A common stock and will vest on the earlier of the company’s next annual shareholder meeting or June 30, 2027. Following this award, Briggs holds 223,423 shares of Petco common stock in total, reflecting a larger equity stake aligned with shareholders.
Yen Iris reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. director Iris Yen reported an equity compensation grant in the form of restricted stock units. She received 60,662 RSUs, each representing one share of Class A common stock, granted at no cash cost under the company’s 2021 Equity Incentive Plan.
The RSUs will vest on the earlier of Petco’s next annual shareholder meeting or June 30, 2027. Following this grant, Yen directly holds 206,449 shares of Class A common stock and has an additional 1,983 shares held indirectly through the Yen-Geniblazo Family Trust.
Breitner Cameron reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company director Cameron Breitner reported an equity award and updated holdings. Breitner received 60,662 restricted stock units (RSUs) of Class A common stock as a grant under Petco’s 2021 Equity Incentive Plan, with no purchase price.
Each RSU equals one share and will vest on the earlier of Petco’s next annual shareholder meeting or June 30, 2027. After the grant, Breitner holds 153,338 Class A shares directly and 750,000 shares indirectly through an LLC jointly owned with his spouse, reflecting a prior transfer from a trust that did not change his beneficial ownership.
MOHAN RAJENDRA M reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. director Rajendra M. Mohan received a grant of 60,662 restricted stock units (RSUs) of Class A common stock as equity compensation. Each RSU equals one share, bringing his direct holdings to 583,689 shares after the award.
The RSUs were granted under Petco’s 2021 Equity Incentive Plan and will vest on the earlier of the company’s next annual shareholder meeting or June 30, 2027. This is a stock-based compensation award, not an open-market purchase.
Petco Health and Wellness Company, Inc. held its 2026 annual meeting of stockholders, where investors approved several governance items and an increase to the company’s equity compensation pool.
Stockholders approved a Second Amendment to the 2021 Equity Incentive Plan, adding 15,500,000 shares of Class A common stock reserved for employee and director equity awards. They also re-elected four Class III directors—Joel Anderson, Gary Briggs, Nishad Chande, and Mary Sullivan—to three-year terms.
In addition, stockholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers and ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending January 30, 2027.